Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals.

ABSTRACT: Ketamine improves motivation-related symptoms in depression but simultaneously elicits similar symptoms in healthy individuals, suggesting that it might have different effects in health and disease. This study examined whether ketamine affects the brain's fronto-striatal system, which is known to drive motivational behavior. The study also assessed whether inflammatory mechanisms-which are known to influence neural and behavioral motivational processes-might underlie some of these changes. These questions were explored in the context of a double-blind, placebo-controlled, crossover trial of ketamine in 33 individuals with treatment-resistant major depressive disorder (TRD) and 25 healthy volunteers (HVs). Resting-state functional magnetic resonance imaging (rsfMRI) was acquired 2 days post

SUBMITTER: Mkrtchian A 

PROVIDER: S-EPMC8462973 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature